A
Atea Pharmaceuticals, Inc. (AVIR)
5.12
0.00 (0.00%)

5.12
0.00 (0.00%)
This stock has a consensus price target of $8.00 based on the ratings of 3 analysts. The high is $10.00 and the low is $6.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 6 | $ 8 | $ 10 |
| O’zgarish | 17.19% | 56.25% | 95.31% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-09 | 95.31% | Evercore ISI Group | $6 → $10 | Maintains | Outperform |
| 2025-04-11 | 17.19% | Morgan Stanley | $6.2 → $6 | Maintains | Equal-Weight |
| 2024-08-13 | 34.38% | Morgan Stanley | $2 → $6.88 | Upgrades | Underweight → Equal-Weight |